http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009132598-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_242cc8d15c771395b920cc7de452da6a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L41-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C04B35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L41-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L41-187
filingDate 2008-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff1d40f9c89397a0742d354d08d7c98e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0e304a377fe3709e11485a0570d11b4
publicationDate 2009-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009132598-A
titleOfInvention Piezoelectric / electrostrictive body and piezoelectric / electrostrictive element
abstract A piezoelectric / electrostrictive body and a piezoelectric / electrostrictive element having an increased strain rate without requiring a long-time treatment such as an aging treatment. A piezoelectric / electrostrictive body includes a composition formula ABO 3 (A is at least one element selected from Li, Na, and K, and B is selected from at least Nb, Ta, Sb, and Mn. The main phase is tetragonal, and the orientation degree of the (00l) plane after the polarization treatment is perpendicular to the direction of application of the electric field applied for the polarization treatment. It is formed so as to be smaller than the degree of orientation of the (100) plane. The piezoelectric / electrostrictive body of the present invention has a diffraction peak intensity I 00l on the (00l) plane and a diffraction peak on the (100) plane in the X-ray diffraction pattern on the plane perpendicular to the direction of application of the electric field after the polarization treatment. the ratio of the intensity I L00 is I 00l / I l00 ≦ 1. [Selection] Figure 2
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016528151-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2364852-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9209384-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013241314-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018133458-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012139919-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011211139-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9318690-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019055908-A
priorityDate 2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007204336-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009046373-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007281439-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6100505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449316130
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID510761
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID65047
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11726
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447714893
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14776
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453986248

Total number of triples: 42.